Over 90 percent of people around the world are exposed to unhealthy air, according to the World Health Organization. In 2019, ambient air pollution was responsible for 4.2 million premature deaths. That’s roughly the number of people who visit Manhattan on a typical weekday.
Independent of the temperature and humidity carried by the airflow, portable respiratory sensors are capable of continuously detecting respiratory intensity and frequency. Respiratory monitoring assesses physiological status and potential disease, preventing the escalation of adverse health conditions through early detection of recurrent wheezing, sleep apnoea and diabetes-induced kussmaul breathing.
New research by scientists at the American Cancer Society (ACS) shows patients impacted by a wildfire disaster while recovering from lung cancer surgery have a longer in-hospital length of stay (LOS) than similar patients treated at the same facility at times when no disasters happened. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.
UAlbany researchers have identified a genetic mechanism that allows antimicrobial resistance to spread among Klebsiella pneumoniae — the third leading cause of blood infections globally.
Coronavirus disease 2019 (COVID-19) has affected not only individual lives but also the world and global systems, both natural and human-made. Besides millions of deaths and environmental challenges, the rapid spread of the infection and its very high socioeconomic impact have affected healthcare, economic status and wealth, and mental health across the globe. To better appreciate the pandemic's influence, multidisciplinary and interdisciplinary approaches are needed. In this paper, together with world-leading scientists from different backgrounds we share collectively our views about the pandemic's footprint and discuss challenges that face the international community.
Nadia Hansel, M.D., a pulmonary and critical care physician and expert in the environmental determinants of obstructive lung diseases, has been named director of the Department of Medicine at the Johns Hopkins University School of Medicine and physician-in-chief of The Johns Hopkins Hospital. Hansel is the William Osler Professor of Medicine. She is the first woman to lead the storied Department of Medicine in its 131-year history.
A pilot study shows that a new wearable lung sensor combined with deep learning can automatically detect wheezes, a common indicator of asthma and COPD
With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall. The new data comes just as this year’s flu shot rolls out and following the FDA’s approval of an updated round of COVID-19 vaccines.
A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.
Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features compelling data on lung cancer advances presented by MD Anderson researchers at the 2024 World Conference on Lung Cancer.
CSA Medical Inc., developer of The RejuvenAir® System, a Breakthrough Medical Device advancing the power of liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, today announced the completion of an oversubscribed $53 million Series D preferred stock equity financing.
MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.
Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19. The findings, published in Nature, may lead to new therapeutic treatment options.
Internationally recognized cancer expert Dr. Miguel A. Villalona-Calero has joined the UCI Health Chao Family Comprehensive Cancer Center as its deputy director and chief of the Division of Hematology-Oncology at the UC Irvine School of Medicine.